Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2933088213;88214;88215 chr2:178557274;178557273;178557272chr2:179422001;179422000;179421999
N2AB2768983290;83291;83292 chr2:178557274;178557273;178557272chr2:179422001;179422000;179421999
N2A2676280509;80510;80511 chr2:178557274;178557273;178557272chr2:179422001;179422000;179421999
N2B2026561018;61019;61020 chr2:178557274;178557273;178557272chr2:179422001;179422000;179421999
Novex-12039061393;61394;61395 chr2:178557274;178557273;178557272chr2:179422001;179422000;179421999
Novex-22045761594;61595;61596 chr2:178557274;178557273;178557272chr2:179422001;179422000;179421999
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTC
  • RefSeq wild type template codon: CAG
  • Domain: Fn3-101
  • Domain position: 94
  • Structural Position: 127
  • Q(SASA): 0.2481
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/A rs1701877919 None 0.997 N 0.676 0.333 0.60416271137 gnomAD-4.0.0 4.80129E-06 None None None None N None 0 0 None 0 0 None 0 0 3.9375E-06 0 3.66327E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.3797 ambiguous 0.3338 benign -1.617 Destabilizing 0.997 D 0.676 prob.neutral N 0.480733173 None None N
V/C 0.7513 likely_pathogenic 0.7421 pathogenic -1.049 Destabilizing 1.0 D 0.816 deleterious None None None None N
V/D 0.9219 likely_pathogenic 0.9115 pathogenic -1.574 Destabilizing 0.999 D 0.851 deleterious N 0.508245177 None None N
V/E 0.7646 likely_pathogenic 0.715 pathogenic -1.42 Destabilizing 0.999 D 0.887 deleterious None None None None N
V/F 0.3225 likely_benign 0.2939 benign -0.972 Destabilizing 0.999 D 0.865 deleterious N 0.480986662 None None N
V/G 0.6205 likely_pathogenic 0.5878 pathogenic -2.061 Highly Destabilizing 0.999 D 0.857 deleterious N 0.508245177 None None N
V/H 0.8582 likely_pathogenic 0.8397 pathogenic -1.489 Destabilizing 1.0 D 0.856 deleterious None None None None N
V/I 0.0899 likely_benign 0.0914 benign -0.424 Destabilizing 0.994 D 0.623 neutral N 0.47670675 None None N
V/K 0.7716 likely_pathogenic 0.7286 pathogenic -1.324 Destabilizing 0.999 D 0.889 deleterious None None None None N
V/L 0.3146 likely_benign 0.3141 benign -0.424 Destabilizing 0.994 D 0.64 neutral N 0.466717068 None None N
V/M 0.2107 likely_benign 0.2001 benign -0.404 Destabilizing 0.999 D 0.713 prob.delet. None None None None N
V/N 0.7666 likely_pathogenic 0.7504 pathogenic -1.489 Destabilizing 0.999 D 0.834 deleterious None None None None N
V/P 0.981 likely_pathogenic 0.9843 pathogenic -0.791 Destabilizing 0.999 D 0.881 deleterious None None None None N
V/Q 0.6393 likely_pathogenic 0.5966 pathogenic -1.413 Destabilizing 0.999 D 0.861 deleterious None None None None N
V/R 0.7008 likely_pathogenic 0.6489 pathogenic -1.065 Destabilizing 0.999 D 0.845 deleterious None None None None N
V/S 0.5545 ambiguous 0.514 ambiguous -2.099 Highly Destabilizing 0.999 D 0.879 deleterious None None None None N
V/T 0.3425 ambiguous 0.3028 benign -1.801 Destabilizing 0.998 D 0.633 neutral None None None None N
V/W 0.9467 likely_pathogenic 0.9424 pathogenic -1.307 Destabilizing 1.0 D 0.841 deleterious None None None None N
V/Y 0.786 likely_pathogenic 0.7681 pathogenic -0.925 Destabilizing 0.999 D 0.851 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.